Payers prefer objective data on mental health medications

April 14, 2017 Tom Valentino

Tom Valentino, Senior Editor

Many mental health advocacy groups push for greater input from patients in clinical trials, but new research shows payers are more interested in objective data that measures new medications’ effectiveness.

Previous Article
Opioid prescribing limits earn bipartisan support

Julie Miller, Editor in ChiefSenators John McCain (R-Ariz.) and Kirsten Gillibrand (D-N.Y.) proposed legisl...

Next Article
Five ways to prepare for the future

Julie Miller, Editor in ChiefWe asked a number of technology leaders for suggestions on what treatment cent...

×

Have Behavioral Health Business updates sent to your inbox today!

First Name
Last Name
Thank you!
Error - something went wrong!